CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Lidocaine Hydrochloride +2 moredrug
Likely dose
Lidocaine Hydrochloride 1.8mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04585061
NCT04585061N/ACompleted

A Novel Approach in Reducing Dental Pain and Anxiety of Pediatric Patient During Local Anesthesia. A Clinical Experimental Study

Riyadh Elm University·interventional·Posted Oct 14, 2020·Updated Nov 11, 2021

In Brief

A clinical study evaluating Lidocaine Hydrochloride, Virtual reality device (Harga Miniso Vr Glass 3d terbaru), and 1 other intervention for Anxiety and Pain. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The aim of this study is to determine the efficacy of sweet in compare to virtual reality (VR) device in reducing injection pain and anxiety associated with local anesthesia in pediatric dental patients. The clinical trial is a randomized split-mouth assignment. Included patients are 5 - 12 years old requiring local anesthetic infiltration with conventional syringe (CS) for conservative treatment of two primary maxillary molars bilaterally. Eligible patients undergo two single-visit treatments after CFSS-DS measurement before each, whereas sweet is allocated to first local anesthesia procedure and VR is allocated to second local anesthesia procedure. Primary outcome measure will be pain felt during injection, reported by patient on visual analogue scale (VAS). Secondary outcome measures: self-reported anxiety during injection on FIS; pain-related behavior according to FLACC scale; heart-rate dynamics; patient preference to local anesthesia method - CS+sweet or CS+VR.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety, Pain
CountriesSaudi Arabia
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 14, 2020
Enrollment StartNov 1, 2020
Primary CompletionFeb 18, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5.7 years ago

Interventions

Lidocaine Hydrochloridedrug

1.8ml of 2%Lidocaine HCl to be administered via a 21mm needle

Virtual reality device (Harga Miniso Vr Glass 3d terbaru)device

Virtual reality device (Harga Miniso Vr Glass 3d terbaru) is placed on the face of the patient, playing a video of Tom and Jerry cartoon. Buccal infiltration in posterior maxillary region with traditional technique. A 27 gauge short needle is inserted in the mucobuccal fold above the tooth to be anesthetized

Xylitoldietary

Buccal infiltration in posterior maxillary region with traditional technique. A 27 gauge short needle is inserted in the mucobuccal fold above the tooth to be anesthetized while xylitol tablet putted under tongue